Impact of Comorbidities and Comedications on the Effectiveness of Ombitasvir/Paritaprevir/Ritonavir +/- Dasabuvir +/- Ribavirin in Clinical Practice: Real-World Evidence From a Multicountry Postmarketing Observational Study

Bourgeois Stefan; Curescu Manuela G.; Larrey Dominique G.; Marra Fiona; Dorr Patrick; Charafeddine Mariem; Crown Eric; Bondin Mark; Back David J.

首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >Impact of Comorbidities and Comedications on the Effectiveness of Ombitasvir/Paritaprevir/Ritonavir +/- Dasabuvir +/- Ribavirin in Clinical Practice: Real-World Evidence From a Multicountry Postmarketing Observational Study

【24h】

Impact of Comorbidities and Comedications on the Effectiveness of Ombitasvir/Paritaprevir/Ritonavir +/- Dasabuvir +/- Ribavirin in Clinical Practice: Real-World Evidence From a Multicountry Postmarketing Observational Study

机译：合并症和伴娘对临床实践中的植物中vir / paritaprevir / ritonavir +/- dasabuvir +/-利巴韦林的影响：来自多腔市邮政观察研究的现实世界证据

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Hepatology: Official Journal of the American Association for the Study of Liver Diseases 》 |2017年第1期| 共1页
作者
Bourgeois Stefan; Curescu Manuela G.; Larrey Dominique G.; Marra Fiona; Dorr Patrick; Charafeddine Mariem; Crown Eric; Bondin Mark; Back David J.;
展开▼
作者单位

ZNA Stuivenberg Dept Gastroenterol &

Hepatol Antwerp Belgium;

Univ Med &

Farm Timisoara Clin Infect Dis Timisoara Romania;

Hop St Eloi Hepatogastroenterol Montpellier France;

Univ Liverpool Dept Mol &

Clin Pharmacol Liverpool Merseyside England;

AbbVie N Chicago IL USA;

AbbVie N Chicago IL USA;

AbbVie N Chicago IL USA;

AbbVie N Chicago IL USA;

Univ Liverpool Dept Mol &

Clin Pharmacol Liverpool Merseyside England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病 ;
关键词

相似文献

外文文献

1. Impact of Comorbidities and Comedications on the Effectiveness of Ombitasvir/Paritaprevir/Ritonavir +/- Dasabuvir +/- Ribavirin in Clinical Practice: Real-World Evidence From a Multicountry Postmarketing Observational Study [J] . Bourgeois Stefan, Curescu Manuela G., Larrey Dominique G., Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017 ,第Suppla1期

机译：合并症和伴娘对临床实践中的植物中vir / paritaprevir / ritonavir +/- dasabuvir +/-利巴韦林的影响：来自多腔市邮政观察研究的现实世界证据
2. Real‐world safety and effectiveness of ombitasvir/paritaprevir/ritonavir?±?dasabuvir?±?ribavirin in hepatitis C virus genotype 1‐ and 4‐infected patients with diverse comorbidities and comedications: A pooled analysis of post‐marketing observational studies from 13 countries [J] . Ferenci Peter, Bourgeois Stefan, Buggisch Peter, Journal of viral hepatitis. . 2019 ,第6期

机译：Imbatasvir / Paritaprevir / ritonavir的真实安全和有效性？
3. Real-world effectiveness and safety of ombitasvir/paritaprevir/ritonavir +/- dasabuvir +/- ribavirin in hepatitis C: AMBER study [J] . Flisiak R., Janczewska E., Wawrzynowicz-Syczewska M., Alimentary pharmacology & therapeutics. . 2016 ,第9期

机译：ombitasvir / paritaprevir / ritonavir +/- dasabuvir +/-利巴韦林在丙型肝炎中的实际疗效和安全性：AMBER研究
4. Effect of comedication on ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin therapy in chronic hepatitis C – a real-world study [O] . Krzysztof Adam Simon, Robert Flisiak, Tadeusz Wojciech Łapiński, 2019

机译：喜剧对慢性丙型肝炎中ombitasvir / paritaprevir / ritonavir±达沙布韦±利巴韦林治疗的影响–一项现实研究
5. Effect of comedication on ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin therapy in chronic hepatitis C – a real-world study [O] . Krzysztof Simon, Robert Flisiak, Tadeusz Łapiński, 2019

机译：同表在慢性丙型肝炎中对植物瘤/帕管雷维尔/ ritonavir±dasabuvir +利巴韦林治疗的影响 - 真实世界研究

Impact of Comorbidities and Comedications on the Effectiveness of Ombitasvir/Paritaprevir/Ritonavir +/- Dasabuvir +/- Ribavirin in Clinical Practice: Real-World Evidence From a Multicountry Postmarketing Observational Study

著录项

相似文献

相关主题

期刊订阅